Filgotinib: First Approval.
Drugs. 2020 Dec;80(18):1987-1997. doi: 10.1007/s40265-020-01439-0.
Drugs. 2020.
PMID: 33237566
Review.
In the EU, filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs). In Japan, filgotinib is indicate …
In the EU, filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded ina …